Crp Risk Management Ltd vs Ep Biocomposites Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 25, 2026

Key Highlights

The Latest Trading Price of CRP Risk Management Ltd is ₹ 6.18 as of 15 Apr 15:30 . The P/E Ratio of CRP Risk Management Ltd changed from 53 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of EP Biocomposites Ltd changed from 58.8 on March 2023 to 20.1 on March 2025 . This represents a CAGR of -30.08% over 3 years The Market Cap of CRP Risk Management Ltd changed from ₹ 42.66 crore on March 2021 to ₹ 10.32 crore on March 2025 . This represents a CAGR of -24.71% over 5 yearsThe Market Cap of EP Biocomposites Ltd changed from ₹ 33.88 crore on March 2023 to ₹ 20.75 crore on March 2025 . This represents a CAGR of -15.08% over 3 years The Dividend Payout of CRP Risk Management Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of EP Biocomposites Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About CRP Risk Management Ltd

CRP Risk Management Limited was originally incorporated as a private limited company with the name 'CRP Technologies (India) Private Limite'.
Subsequently, the Company was converted into a public limited company and the name of the Company was changed to 'CRP Technologies (India) Limited' on June 23, 2011.
Subsequently, the name of the company was further changed to 'CRP Risk Management Limited? on November 17, 2014. CRP Risk is a risk management and risk mitigation enterprise.
The Company verifies critical information for large and mid-sized corporate.
It provides the services to multiple departments like Finance, Compliance, Operations etc.

About EP Biocomposites Ltd

EP Biocomposites Limited was incorporated as Public Limited Company on January 17, 2020 with the Registrar of Companies, Goa.
Further, pursuant to Business Takeover Agreement dated August 31, 2021, the Company took over the running business of M/s.
OM Ventures, a proprietorship concern through one of its Promoter Leena Kamat.
In September 2022, Company made an Initial Public Offer of 5,04,000 Equity Shares of Rs 10 each by raising funds aggregating to Rs. 6.35 Crore. The Company is involved in manufacturing and supplying of a vast portfolio of products and services, which includes Fibre Glass doors and allied products, Bio Digester Toilets with DRDO technology and actively contributing to wastewater recycling through its solution in Sewage Treatment Plants (STP)and Effluent Treatment Plants (ETP).

FAQs for the comparison of CRP Risk Management Ltd and EP Biocomposites Ltd

Which company has a larger market capitalization, CRP Risk Management Ltd or EP Biocomposites Ltd?

Market cap of CRP Risk Management Ltd is 10 Cr while Market cap of EP Biocomposites Ltd is 17 Cr

What are the key factors driving the stock performance of CRP Risk Management Ltd and EP Biocomposites Ltd?

The stock performance of CRP Risk Management Ltd and EP Biocomposites Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for CRP Risk Management Ltd and EP Biocomposites Ltd?

As of March 25, 2026, the CRP Risk Management Ltd stock price is INR ₹6.18. On the other hand, EP Biocomposites Ltd stock price is INR ₹102.7.

How do dividend payouts of CRP Risk Management Ltd and EP Biocomposites Ltd compare?

To compare the dividend payouts of CRP Risk Management Ltd and EP Biocomposites Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.